[
  {
    "ts": "2025-10-03T11:46:14+00:00",
    "headline": "Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial",
    "summary": "Amgen received a label expansion from the FDA in August 2025.",
    "url": "https://www.clinicaltrialsarena.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "2fb72bb0-021b-384c-a020-8957b7445630",
      "content": {
        "id": "2fb72bb0-021b-384c-a020-8957b7445630",
        "contentType": "STORY",
        "title": "Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial",
        "description": "",
        "summary": "Amgen received a label expansion from the FDA in August 2025.",
        "pubDate": "2025-10-03T11:46:14Z",
        "displayTime": "2025-10-03T11:46:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/8579b2920cc4639037920e8efce71f57",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Amgen is set to present the full data at the American Heart Association Scientific Sessions on 8 November. Image credit: Melnikov Dmitriy / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YcxdlUbDyewW.D1PU016Xw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/8579b2920cc4639037920e8efce71f57.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1DLfaaX94XiecMKSumDKCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/8579b2920cc4639037920e8efce71f57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-phase-iii-data-supports-114614833.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T11:46:14+00:00",
    "headline": "Amgen’s Phase III data supports FDA label expansion of Repatha",
    "summary": "Amgen received a label expansion from the FDA in August 2025, with the VESALIUS-CV data supporting this decision.",
    "url": "https://www.pharmaceutical-technology.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "c32316f3-cddd-34b2-9465-13c1a92b42f6",
      "content": {
        "id": "c32316f3-cddd-34b2-9465-13c1a92b42f6",
        "contentType": "STORY",
        "title": "Amgen’s Phase III data supports FDA label expansion of Repatha",
        "description": "",
        "summary": "Amgen received a label expansion from the FDA in August 2025, with the VESALIUS-CV data supporting this decision.",
        "pubDate": "2025-10-03T11:46:14Z",
        "displayTime": "2025-10-03T11:46:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/a7973cc3e5fe6474ce87087b2158e11c",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A0qZ8hRIo2rtQmjD71esrw--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/a7973cc3e5fe6474ce87087b2158e11c.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZslXg8.XtkdZZd7aVTM_Og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/a7973cc3e5fe6474ce87087b2158e11c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-phase-iii-data-supports-114614011.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T10:42:00+00:00",
    "headline": "September in Review: 11 Top Health Press Releases",
    "summary": "With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and newsworthy trends, here's a recap of some of the past month's most read- and engaged-with stories.",
    "url": "https://finance.yahoo.com/news/september-review-11-top-health-104200953.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b5f3a13b-d393-3a34-b7cb-8489409da697",
      "content": {
        "id": "b5f3a13b-d393-3a34-b7cb-8489409da697",
        "contentType": "STORY",
        "title": "September in Review: 11 Top Health Press Releases",
        "description": "",
        "summary": "With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and newsworthy trends, here's a recap of some of the past month's most read- and engaged-with stories.",
        "pubDate": "2025-10-03T10:42:00Z",
        "displayTime": "2025-10-03T10:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1e279774439da4e9cee29124c6063931",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "PR Newswire Monthly Health Press Release Roundup, September 2025.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0vbTP59.YIAAaENT43dQ8w--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1e279774439da4e9cee29124c6063931.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gs1nlK76N3QI_kcDY51BCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1e279774439da4e9cee29124c6063931.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/september-review-11-top-health-104200953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/september-review-11-top-health-104200953.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]